Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review

Immune-related adverse events have been reported in patients treated with anti-programmed death-1 receptor drugs such as nivolumab. We present a case of a new-onset seronegative rheumatoid arthritis in a patient with metastatic melanoma treated with nivolumab.

Guardado en:
Detalles Bibliográficos
Autores principales: Ammar Haikal, E Borba, Taqui Khaja, Gary Doolittle, Paul Schmidt
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018
Materias:
R
Acceso en línea:https://doaj.org/article/627788216e75443c974026dac7c3122c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!